{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T10:19:09Z","timestamp":1761733149003,"version":"build-2065373602"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10157-025-02696-7","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T09:09:39Z","timestamp":1747300179000},"page":"1503-1514","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trend of treatment strategy for amyloid light-chain amyloidosis: a-single center experience"],"prefix":"10.1007","volume":"29","author":[{"given":"Yoshifumi","family":"Ubara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Kono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiko","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Wake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"2696_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1056\/NEJM199704243361702","volume":"336","author":"RA Kyle","year":"1997","unstructured":"Kyle RA, Gertz MA, Greipp PR, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997;336:1202\u20137.","journal-title":"N Engl J Med"},{"key":"2696_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae285","author":"N Senot","year":"2024","unstructured":"Senot N, Gibier JB, Rabant M, Esteve E, Ferriere E, Dessaix K, Colombat M, Perrochia H, Olagne J, Goujon JM, Wayolle N, Wemeau M, Carpentier B, Pinson P, Beeker N, Bridoux F, Cohen C. Epidemiological and clinicopathological characteristics of vascular-limited renal AL amyloidosis. Nephrol Dial Transplant. 2024. https:\/\/doi.org\/10.1093\/ndt\/gfae285.","journal-title":"Nephrol Dial Transplant"},{"key":"2696_CR3","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1182\/blood.V99.12.4276","volume":"99","author":"RL Comenzo","year":"2002","unstructured":"Comenzo RL, Gertz MA. Autologous stem cell transplantation for primary systemic amyloidosis. Blood. 2002;99:4276\u201382.","journal-title":"Blood"},{"key":"2696_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.2169\/internalmedicine.42.72","volume":"42","author":"T Gono","year":"2003","unstructured":"Gono T, Matsuda M, Dohi N, et al. Nephrotic syndrome due to primary AL amyloidosis, successfully treated with VAD and subsequent high-dose melphalan followed by autologous peripheral blood stem cell transplantation. Intern Med. 2003;42:72\u20137.","journal-title":"Intern Med"},{"key":"2696_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/13506120412331336907","volume":"11","author":"T Gono","year":"2004","unstructured":"Gono T, Matsuda M, Shimojima Y, et al. VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection. Amyloid. 2004;11:245\u201356.","journal-title":"Amyloid"},{"issue":"6","key":"2696_CR6","first-page":"414","volume":"1","author":"J Hoshino","year":"2008","unstructured":"Hoshino J, Ubara Y, Ohashi K, Takemoto F, Takaichi K. Pathologic improvement after high-dose melphalan and autologous stem cell transplantation for primary systemic amyloidosis. NDT Plus. 2008;1(6):414\u20136.","journal-title":"NDT Plus"},{"issue":"5","key":"2696_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2169\/internalmedicine.9263-17","volume":"57","author":"D Iwadate","year":"2018","unstructured":"Iwadate D, Hasegawa E, Hoshino J, Hayami N, Sumida K, Yamanouchi M, Sekine A, Kawada M, Hiramatsu R, Suwabe T, Sawa N, Yuasa M, Wake A, Fujii T, Ohashi K, Takaichi K, Ubara Y. The long-term outcomes after VAD plus SCT therapy in a patient with AL amyloidosis and severe factor X deficiency. Intern Med. 2018;57(5):701\u20136.","journal-title":"Intern Med"},{"issue":"5","key":"2696_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s10157-009-0198-y","volume":"13","author":"O Yamazaki","year":"2009","unstructured":"Yamazaki O, Ubara Y, Suwabe T, Nakanishi S, Hoshino J, Sawa N, Hayami N, Yamanouchi M, Takemoto F, Kenmei T, Masuoka K, Oohashi K. Successful treatment of primary AL amyloidosis by VAD therapy, high-dose melphalan, and autologous peripheral stem cell transplantation. Clin Exp Nephrol. 2009;13(5):522\u20135.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2696_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s13730-019-00416-1","volume":"9","author":"N Toriu","year":"2020","unstructured":"Toriu N, Sawa N, Hiramatsu R, Mizuno H, Ikuma D, Sekine A, Hayami N, Sumida K, Yamanouchi M, Hasegawa E, Hoshino J, Takaichi K, Wake A, Ohashi K, Fujii T, Ubara Y. Regression of renal amyloid deposits by VAD therapy plus autologous stem cell transplantation in a patient with primary AL amyloidosis. CEN Case Rep. 2020;9(1):6\u201310.","journal-title":"CEN Case Rep"},{"issue":"4","key":"2696_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s13730-023-00777-8","volume":"12","author":"T Iijima","year":"2023","unstructured":"Iijima T, Sawa N, Oba Y, Ikuma D, Mizuno H, Yamanouchi M, Suwabe T, Wake A, Kono K, Ubara Y, Ohashi K. Cardiac and renal AL amyloidosis controlled by autologous stem cell transplantation for 17 years accompanying late onset atrial fibrillation and complete atrioventricular block. CEN Case Rep. 2023;12(4):362\u20137.","journal-title":"CEN Case Rep"},{"issue":"4","key":"2696_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s10157-011-0426-0","volume":"15","author":"J Hoshino","year":"2011","unstructured":"Hoshino J, Ubara Y, Sawa N, Sumida K, Hiramatsu R, Hasegawa E, Suwabe T, Hayami N, Yamanouchi M, Takemoto F, Taniguchi S, Takaichi K. How to treat patients with systemic amyloid light chain amyloidosis? Comparison of high-dose melphalan, low-dose chemotherapy and no chemotherapy in patients with or without cardiac amyloidosis. Clin Exp Nephrol. 2011;15(4):486\u201392.","journal-title":"Clin Exp Nephrol"},{"issue":"17","key":"2696_CR12","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.2169\/internalmedicine.55.6796","volume":"55","author":"T Ueno","year":"2016","unstructured":"Ueno T, Sumida K, Hoshino J, Suwabe T, Mise K, Hazue R, Hayami N, Hiramatsu R, Kawada M, Imafuku A, Hasegawa E, Sawa N, Takaichi K, Kinowaki K, Ohashi K, Fujii T, Nishida A, Ubara Y. AA-negative and Kappa-positive amyloidosis in a patient with rheumatoid arthritis. Intern Med. 2016;55(17):2491\u20135.","journal-title":"Intern Med"},{"issue":"19","key":"2696_CR13","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.2169\/internalmedicine.9039-21","volume":"61","author":"T Iijima","year":"2022","unstructured":"Iijima T, Sawa N, Nakayama Y, Oba Y, Ikuma D, Mizuno H, Yamanouchi M, Suwabe T, Wake A, Kono K, Hoshino J, Ubara Y, Ohashi K. Vincristine, doxorubicin, and dexamethasone induction before autologous stem cell transplantation in patients with AL amyloidosis: A retrospective comparison with frontline stem cell transplantation. Intern Med. 2022;61(19):2853\u201360.","journal-title":"Intern Med"},{"issue":"24","key":"2696_CR14","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMra2304088","volume":"390","author":"V Sanchorawala","year":"2024","unstructured":"Sanchorawala V. Systemic light chain amyloidosis. N Engl J Med. 2024;390(24):2295\u2013307.","journal-title":"N Engl J Med"},{"key":"2696_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3109\/13506129.2013.807790","volume":"20","author":"A Tsuchiya-Suzuki","year":"2013","unstructured":"Tsuchiya-Suzuki A, Yazaki M, Sekijima Y, Kametani F, Ikeda S. Steady turnover of amyloid fibril proteins in gastric mucosa after liver transplantation in familial amyloid polyneuropathy. Amyloid. 2013;20:156\u201363.","journal-title":"Amyloid"},{"issue":"9","key":"2696_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/pin.13466","volume":"74","author":"K Kono","year":"2024","unstructured":"Kono K, Sawa N, Wake A, Shintani-Domoto Y, Fujii T, Takazawa Y, Ubara Y, Ohashi K. Digital whole-slide imaging of changes in amyloid after peripheral blood stem cell transplantation in patients with amyloid light-chain amyloidosis. Pathol Int. 2024;74(9):508\u201319.","journal-title":"Pathol Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-025-02696-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-025-02696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:33:51Z","timestamp":1761708831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-025-02696-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2696"],"URL":"https:\/\/doi.org\/10.1007\/s10157-025-02696-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"type":"print","value":"1342-1751"},{"type":"electronic","value":"1437-7799"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests and no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present report was produced in conformity with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}